{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:18:42Z","timestamp":1789978722410,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,8,11]],"date-time":"2011-08-11T00:00:00Z","timestamp":1313020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00432-011-1016-y","type":"journal-article","created":{"date-parts":[[2011,8,10]],"date-time":"2011-08-10T14:56:09Z","timestamp":1312988169000},"page":"1535-1544","source":"Crossref","is-referenced-by-count":47,"title":["Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation"],"prefix":"10.1007","volume":"137","author":[{"given":"Yusuf","family":"Baran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Bielawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuk","family":"Gunduz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Besim","family":"Ogretmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,11]]},"reference":[{"key":"1016_CR1","doi-asserted-by":"crossref","first-page":"10922","DOI":"10.1074\/jbc.M610157200","volume":"282","author":"Y Baran","year":"2007","unstructured":"Baran Y, Salas A, Senkal CE, Gunduz U, Bielawski J, Obeid LM, Ogretmen B (2007) Alterations of ceramide\/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells. J Biol Chem 282:10922\u201310934","journal-title":"J Biol Chem"},{"issue":"5","key":"1016_CR2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/leu.2008.95","volume":"22","author":"E Bonhoure","year":"2008","unstructured":"Bonhoure E, Lauret A, Barnes DJ, Martin C, Malavaud B, Kohama T, Melo JV, Cuvillier O (2008) Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells. Leukemia 22(5):971\u2013979","journal-title":"Leukemia"},{"key":"1016_CR3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0092-8674(95)90429-8","volume":"82","author":"R Bose","year":"1995","unstructured":"Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82:405\u2013414","journal-title":"Cell"},{"key":"1016_CR4","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1200\/JCO.1998.16.11.3674","volume":"16","author":"DM Bradshaw","year":"1998","unstructured":"Bradshaw DM, Arceci RJ (1998) Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance. J Clin Oncol 16:3674\u20133690","journal-title":"J Clin Oncol"},{"key":"1016_CR5","first-page":"100","volume":"56","author":"E Buchdunger","year":"1996","unstructured":"Buchdunger E, Zimmermann J, Mett H, Meyer T, M\u00fcller M, Druker BJ, Lydon NB (1996) Inhibition of the abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 56:100\u2013104","journal-title":"Cancer Res"},{"key":"1016_CR6","first-page":"880","volume":"59","author":"MC Cabot","year":"1999","unstructured":"Cabot MC, Giuliano AE, Han TY, Liu YY (1999) Sdz psc 833, the cyclosporine a analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells. Cancer Res 59:880\u2013885","journal-title":"Cancer Res"},{"key":"1016_CR7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1172\/JCI1180","volume":"102","author":"GS Dbaibo","year":"1998","unstructured":"Dbaibo GS, Pushkareva MY, Rachid RA, Alter N, Smyth MJ, Obeid LM, Hannun YA (1998) P53-dependent ceramide response to genotoxic stress. J Clin Invest 102:329\u2013339","journal-title":"J Clin Invest"},{"key":"1016_CR8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.6004\/jnccn.2005.0045","volume":"3","author":"M Deininger","year":"2005","unstructured":"Deininger M (2005) Resistance to imatinib: mechanisms and management. J Natl Compr Canc Netw 3:757\u2013768","journal-title":"J Natl Compr Canc Netw"},{"key":"1016_CR9","first-page":"884","volume":"237","author":"AJ Hale","year":"1996","unstructured":"Hale AJ, Smith CA, Sutherland LC, Stoneman VE, Longthorne V, Culhane AC, Williams GT (1996) Apoptosis: molecular regulation of cell death. Eur J Biochem 237:884","journal-title":"Eur J Biochem"},{"key":"1016_CR10","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1126\/science.274.5294.1855","volume":"274","author":"YA Hannun","year":"1996","unstructured":"Hannun YA (1996) Functions of ceramide in coordinating cellular responses to stress. Science 274:1855\u20131859","journal-title":"Science"},{"key":"1016_CR11","doi-asserted-by":"crossref","first-page":"25847","DOI":"10.1074\/jbc.R200008200","volume":"277","author":"YA Hannun","year":"2002","unstructured":"Hannun YA, Obeid LM (2002) The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 277:25847\u201325850","journal-title":"J Biol Chem"},{"key":"1016_CR12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0925-4439(02)00095-9","volume":"1587","author":"T Hegedus","year":"2002","unstructured":"Hegedus T, Orfi L, Seprodi A, Varadi A, Sarkadi B, Keri G (2002) Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, mdr1 and mrp1. Biochim Biophys Acta 1587:318\u2013325","journal-title":"Biochim Biophys Acta"},{"key":"1016_CR13","first-page":"6731","volume":"50","author":"J Inokuchi","year":"1990","unstructured":"Inokuchi J, Jimbo M, Momosaki K, Shimeno H, Nagamatsu A, Radin NS (1990) Inhibition of experimental metastasis of murine lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action. Cancer Res 50:6731\u20136737","journal-title":"Cancer Res"},{"key":"1016_CR100","unstructured":"Koca E, Haznedaroglu IC (2005) Imatinib mesylate and the management of chronic myeloid leukemia (CML). Turk J Hematol 2(4):161\u2013172"},{"key":"1016_CR14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/1097-0215(20000715)87:2<172::AID-IJC3>3.0.CO;2-K","volume":"87","author":"JW Kok","year":"2000","unstructured":"Kok JW, Veldman RJ, Klappe K, Koning H, Filipeanu CM, Muller M (2000) Differential expression of sphingolipids in mrp1 overexpressing ht29 cells. Int J Cancer 87:172\u2013178","journal-title":"Int J Cancer"},{"key":"1016_CR15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1146\/annurev.physiol.60.1.643","volume":"60","author":"RN Kolesnick","year":"1998","unstructured":"Kolesnick RN, Kronke M (1998) Regulation of ceramide production and apoptosis. Annu Rev Physiol 60:643\u2013665","journal-title":"Annu Rev Physiol"},{"key":"1016_CR16","doi-asserted-by":"crossref","first-page":"44311","DOI":"10.1074\/jbc.M406920200","volume":"279","author":"S Koybasi","year":"2004","unstructured":"Koybasi S, Senkal CE, Sundararaj K, Spassieva S, Bielawski J, Osta W, Day TA, Jiang JC, Jazwinski SM, Hannun YA, Obeid LM, Ogretmen B (2004) Defects in cell growth regulation by c18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J Biol Chem 279:44311\u201344319","journal-title":"J Biol Chem"},{"key":"1016_CR17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1054\/drup.2000.0176","volume":"4","author":"GW Krystal","year":"2001","unstructured":"Krystal GW (2001) Mechanisms of resistance to imatinib (sti571) and prospects for combination with conventional chemotherapeutic agents. Drug Resist Updat 4:16\u201321","journal-title":"Drug Resist Updat"},{"key":"1016_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0304-3835(95)04106-0","volume":"101","author":"M Kyogashima","year":"1996","unstructured":"Kyogashima M, Inoue M, Seto A, Inokuchi J (1996) Glucosylceramide synthetase inhibitor, d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol exhibits a novel decarcinogenic activity against shope carcinoma cells. Cancer Lett 101:25\u201330","journal-title":"Cancer Lett"},{"key":"1016_CR19","doi-asserted-by":"crossref","first-page":"19530","DOI":"10.1074\/jbc.271.32.19530","volume":"271","author":"Y Lavie","year":"1996","unstructured":"Lavie Y, Cao H, Bursten SL, Giuliano AE, Cabot MC (1996) Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem 271:19530\u201319536","journal-title":"J Biol Chem"},{"issue":"57","key":"1016_CR20","doi-asserted-by":"crossref","first-page":"7904","DOI":"10.1038\/sj.onc.1210587","volume":"26","author":"QF Li","year":"2007","unstructured":"Li QF, Huang WR, Duan HF, Wang H, Wu CT, Wang LS (2007) Sphingosine kinase-1 mediates BCR\/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells. Oncogene 26(57):7904\u20137908","journal-title":"Oncogene"},{"key":"1016_CR21","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1074\/jbc.274.2.1140","volume":"274","author":"YY Liu","year":"1999","unstructured":"Liu YY, Han TY, Giuliano AE, Cabot MC (1999) Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J Biol Chem 274:1140\u20131146","journal-title":"J Biol Chem"},{"key":"1016_CR22","doi-asserted-by":"crossref","first-page":"7138","DOI":"10.1074\/jbc.275.10.7138","volume":"275","author":"YY Liu","year":"2000","unstructured":"Liu YY, Han TY, Giuliano AE, Hansen N, Cabot MC (2000) Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J Biol Chem 275:7138\u20137143","journal-title":"J Biol Chem"},{"key":"1016_CR23","first-page":"475","volume":"18","author":"A Lucci","year":"1998","unstructured":"Lucci A, Cho WI, Han TY, Giuliano AE, Morton DL, Cabot MC (1998) Glucosylceramide: a marker for multiple-drug resistant cancers. Anticancer Res 18:475\u2013840","journal-title":"Anticancer Res"},{"key":"1016_CR24","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V96.3.1070","volume":"96","author":"FX Mahon","year":"2000","unstructured":"Mahon FX, Deininger MW, Schultheis B, Chabrol J, Reiffers J, Goldman JM, Melo JV (2000) Selection and characterization of bcr-abl positive cell lines with differential sensitivity to the tyrosine kinase inhibitor sti571: diverse mechanisms of resistance. Blood 96:1070\u20131079","journal-title":"Blood"},{"key":"1016_CR25","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1172\/JCI117997","volume":"95","author":"NL Marsh","year":"1995","unstructured":"Marsh NL, Elias PM, Holleran WM (1995) Glucosylceramides stimulate murine epidermal hyperproliferation. J Clin Invest 95:2903\u20132909","journal-title":"J Clin Invest"},{"key":"1016_CR26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0145-2126(99)00048-X","volume":"23","author":"D Myrick","year":"1999","unstructured":"Myrick D, Blackinton D, Klostergaard J, Kouttab N, Maizel A, Wanebo H, Metha S (1999) Paclitaxel-induced apoptosis in jurkat, a leukemic t cell line, is enhanced by ceramide. Leuk Res 23:569\u2013578","journal-title":"Leuk Res"},{"key":"1016_CR27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.bjc.6690711","volume":"81","author":"KM Nicholson","year":"1999","unstructured":"Nicholson KM, Quinn DM, Kellett GL, Warr JR (1999) Preferential killing of multidrug-resistant kb cells by inhibitors of glucosylceramide synthase. Br J Cancer 81:423\u2013430","journal-title":"Br J Cancer"},{"key":"1016_CR28","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrc1411","volume":"4","author":"B Ogretmen","year":"2004","unstructured":"Ogretmen B, Hannun YA (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4:604\u2013616","journal-title":"Nat Rev Cancer"},{"key":"1016_CR29","doi-asserted-by":"crossref","first-page":"24901","DOI":"10.1074\/jbc.M100314200","volume":"276","author":"B Ogretmen","year":"2001","unstructured":"Ogretmen B, Schady D, Usta J, Wood R, Kraveka JM, Luberto C, Birbes H, Hannun YA, Obeid LM (2001) Role of ceramide in mediating the inhibition of telomerase activity in a549 human lung adenocarcinoma cells. J Biol Chem 276:24901\u201324910","journal-title":"J Biol Chem"},{"key":"1016_CR30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0898-6568(98)00035-7","volume":"10","author":"T Okazaki","year":"1998","unstructured":"Okazaki T, Kondo T, Kitano T, Tashima M (1998) Diversity and complexity of ceramide signalling in apoptosis. Cell Signal 10:685\u2013692","journal-title":"Cell Signal"},{"key":"1016_CR31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/10428199809057621","volume":"31","author":"M Perales","year":"1998","unstructured":"Perales M, Cervantes F, Cobo F, Montserrat E (1998) Non-hodgkin\u2019s lymphoma associated with gaucher\u2019s disease. Leuk Lymphoma 31:609\u2013612","journal-title":"Leuk Lymphoma"},{"key":"1016_CR32","first-page":"23","volume":"24","author":"O Piskin","year":"2007","unstructured":"Piskin O, Ozcan MA, Ozsan GH, Ates H, Demirkan F, Alacacioglu I, Undar B (2007) Synergistic effect of imatinib mesylate and fludarabine combination on Philadelphia chromosome-positive chronic myeloid leukemia cell lines. Turk J Haematol 24:23\u201327","journal-title":"Turk J Haematol"},{"key":"1016_CR33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood.V81.1.143.143","volume":"81","author":"LE Robertson","year":"1993","unstructured":"Robertson LE, Chubb S, Meyn RE, Story M, Ford R, Hittelman WN, Plunkett W (1993) Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2\u2032-deoxyadenosine and 9-beta-d-arabinosyl-2-fluoroadenine. Blood 81:143\u2013150","journal-title":"Blood"},{"key":"1016_CR34","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1074\/jbc.272.4.2452","volume":"272","author":"H Sawai","year":"1997","unstructured":"Sawai H, Okazaki T, Takeda Y, Tashima M, Sawada H, Okuma M, Kishi S, Umehara H, Domae N (1997) Ceramide-induced translocation of protein kinase c-delta and -epsilon to the cytosol implications in apoptosis. J Biol Chem 272:2452\u20132458","journal-title":"J Biol Chem"},{"key":"1016_CR35","first-page":"942","volume":"6","author":"H Sietsma","year":"2000","unstructured":"Sietsma H, Veldman RJ, Kolk D, Ausema B, Nijhof W, Kamps W, Vellenga E, Kok JW (2000) 1-phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for taxol and vincristine. Clin Cancer Res 6:942\u2013948","journal-title":"Clin Cancer Res"},{"key":"1016_CR36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/sj.cdd.4400428","volume":"5","author":"A Spinedi","year":"1998","unstructured":"Spinedi A, Bartolomeo SD, Piacentini M (1998) Apoptosis induced by n-hexanoylsphingosine in chp-100 cells associates with accumulation of endogenous ceramide and is potentiated by inhibition of glucocerebroside synthesis. Cell Death Differ 5:785\u2013791","journal-title":"Cell Death Differ"},{"key":"1016_CR37","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/BJ20051083","volume":"393","author":"I Sultan","year":"2006","unstructured":"Sultan I, Senkal CE, Ponnusamy S, Ponnusamy S, Bielawski J, Szulc Z, Bielawska A, Hannun YA, Ogretmen B (2006) Regulation of the sphingosine-recycling pathway for ceramide generation by oxidative stress, and its role in controlling c-myc\/max function. Biochem J 393:513\u2013521","journal-title":"Biochem J"},{"key":"1016_CR38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.critrevonc.2005.06.007","volume":"57","author":"C Walz","year":"2006","unstructured":"Walz C, Sattler M (2006) Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (cml). Crit Rev Oncol Hematol 57:145\u2013164","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-011-1016-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-011-1016-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-011-1016-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T05:29:19Z","timestamp":1592803759000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-011-1016-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,11]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["1016"],"URL":"https:\/\/doi.org\/10.1007\/s00432-011-1016-y","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,11]]}}}